These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2140913)

  • 21. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y).
    Nieuwenhuizen W; Voskuilen M; Hermans J
    Biochim Biophys Acta; 1982 Nov; 708(3):313-6. PubMed ID: 6216917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrin(-ogen) interactions with plasmin.
    Gaffney PJ
    Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery.
    Hermel M; Dailey W; Hartzer MK
    Curr Eye Res; 2010 May; 35(5):419-24. PubMed ID: 20450255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation product.
    Regañon E; Aznar J; Vila V
    Haemostasis; 1978; 7(1):26-34. PubMed ID: 147811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
    Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
    J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interaction of heavy and light chains of plasmin with fibrinogen E and D fragments].
    Kudinov SA; Lezhen TI
    Biokhimiia; 1984 Dec; 49(12):2003-7. PubMed ID: 6240993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolysis and fibrinogenolysis by Val442-plasmin.
    Ney KA; Pizzo SV
    Biochim Biophys Acta; 1982 Nov; 708(2):218-24. PubMed ID: 6216916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
    Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
    Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrolysis of fibrinogen Paris I by plasmin.
    Mosesson MW; Denninger MH; Ménaché D
    Thromb Res; 1976 Aug; 9(2):115-21. PubMed ID: 135371
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of proteins adsorbed from human plasma to glass bead columns: plasmin-induced degradation of adsorbed fibrinogen.
    Brash JL; Thibodeau JA
    J Biomed Mater Res; 1986; 20(9):1263-75. PubMed ID: 2946694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibition.
    Jespersen J; Gram J; Astrup T
    Thromb Res; 1986 Feb; 41(3):395-404. PubMed ID: 2939586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical and biological properties of human and canine plasmins.
    Takeda Y; Nakabayashi M
    J Clin Invest; 1974 Jan; 53(1):154-62. PubMed ID: 4128408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
    Kolodziejczyk-Czepas J; Talar B; Nowak P; Olas B; Wachowicz B
    Int J Biol Macromol; 2012 Apr; 50(3):754-8. PubMed ID: 22197896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of an active derivative produced from native streptokinase by dog plasmin.
    Reddy KN; Kline DL
    Thromb Res; 1976 Oct; 9(4):407-11. PubMed ID: 136060
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: Streptokinase degradation during the formation of a plasmin(ogen)-fibrinogen complex with activator activity.
    Chesterman CN; Allington MJ; Cederholm-Williams SA; Sharp AA
    Br J Haematol; 1974 Jun; 27(2):365. PubMed ID: 4846464
    [No Abstract]   [Full Text] [Related]  

  • 38. Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity.
    Lottenberg R; DesJardin LE; Wang H; Boyle MD
    J Infect Dis; 1992 Aug; 166(2):436-40. PubMed ID: 1386099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.